Health

[Image]

Enlarge Image

Basic Approach
SVP2016 Review
Towards the New CSR Plan, SVP 2030
FY2017 Topics

Note: The article on this page is taken from Sustainability Report 2017.

Basic Approach

Health is the most personal and important topic for people, yet there is a range of associated problems, such as disparities in medical access, shortage of doctors, increasing burden on medical workers, and surging medical costs. The Fujifilm Group started producing X-ray film in 1936, soon after the company's establishment. Since then we have been a long-term contributor in the field of Medical Diagnosis. Our medical business has recently expanded into the Prevention and Treatment fields, as a part of a strategic move towards the group's growth. We are continuously striving to widen our contribution to promoting people's health and welfare. In this new CSR Plan, we set out four priority issues based on the scale of our contribution to help solving the social challenges, identified through reviewing all the products, services, and technologies that we possess.

< Social Issues > Risks in international society

Aging society
Increased medical costs
Regional divide in medical care
Response to healthy life expectancy
Unmet medical needs
Global healthetc.

[Image] Global number of adult diabetic patients

Health is listed as one of the goals of SDGs. For example, the number of people suffering from diabetes is drastically increasing in many countries, particularly in developing countries, although it is a preventable and treatable disease. One of the disease’s main causes is obesity, an illness of modern society. About 422 million adults had diabetes, with around 1.5 million deaths per year resulting from the illness. The total number of patients is expected to multiply in the next 20 years, and due to this rapidly increasing risk from diabetes across the world, WHO decided to make diabetes the major focus of World Health Day 2016.

[ Priority Issue 1 ] Improve accessibility to medical services

[ Targets ]

(1) Improve the medical environment in emerging countries
(2) Increase medical check opportunities in disaster or emergency situations and improve diagnostic accuracy
(3) Increase the medical check opportunities and improve diagnostic accuracy by reducing the burdens on doctors

[ Priority Issue 2 ] Contribute to identifying diseases at an early stage

[ Target ]

Disseminate medical diagnosis systems with improved accuracy and less physical burden on patients

[ Priority Issue 3 ] Response unmet medical needs

[ Target ]

Develop medicines for diseases without effective treatments

[ Priority Issue 4 ] Promotion of health and contribution to beauty

[ Targets ]

(1) Extend healthy life expectancy and support positive state in everyday life
(2) Assist women in staying healthy, beautiful, and attractive

[Image] Related Business Fields

SVP2016 Review

To achieve its goal of becoming a total healthcare company, the Fujifilm Group has made a great contribution in the four priority issues developing high performance medical equipment and pursuing M&As centered to reinforce our business structure.

1 Improve accessibility to medical services

Our support for education and training in the Middle East and Africa and our introduction of hardware and software solutions, such as portable ultrasonic diagnostic systems and IT solutions for hospitals in emerging and other countries, has enabled us to contribute to improving access to medical services and reducing the burden on medical staff.

2 Contribute to identifying diseases at an early stage

We have contributed to the early detection of diseases through the wider use of endoscopes and other medical diagnostic imaging systems and rapid influenza diagnostic systems.

3 Response unmet medical needs

In addition to developing new drugs targeting cancer, Alzheimer's disease, etc., we are developing processes for manufacturing pharmaceutical products, chiefly for biomedical drugs, that are expected to deliver outstanding efficacy with lower side effects, as well as in manufacturing and expansion of the scope of the production by commission business. We have strengthened our technological and management capabilities to industrialize regenerative medicine, including starting joint research with a number of international research institutes.

4 Promotion of health and contribution to beauty

The expertise we acquired through our research into oxidation resistance for photographic film and our exclusive nanotech technologies have enabled us to create new supplements and cosmetic products that contribute to extending healthy life expectancy and to the active participation of women in society.

Towards the New CSR Plan, SVP 2030

In order to respond to demands for unmet medical needs, we will focus on the development of medicines to treat cancer and infectious diseases, and developments concerning the prevention, diagnosis, and treatment of Alzheimer's dementia. We are also proceeding with projects that: (a) contribute to the treatment of disorders unhealable by conventional medicine through our development of regenerative medicine; (b) promote home medical care to cope with the aging society and alleviate the burden on doctors; (c) enhance early disease detection in emerging and other countries; and (d) extend healthy life expectancy.